D. Araújo , E. Padrão , M. Morais-Almeida , J. Cardoso , F. Pavão , R.B. Leite , A.C. Caldas , A. Marques
{"title":"Asthma-chronic obstructive pulmonary disease overlap syndrome – Literature review and contributions towards a Portuguese consensus","authors":"D. Araújo , E. Padrão , M. Morais-Almeida , J. Cardoso , F. Pavão , R.B. Leite , A.C. Caldas , A. Marques","doi":"10.1016/j.rppnen.2016.11.005","DOIUrl":"10.1016/j.rppnen.2016.11.005","url":null,"abstract":"<div><h3>Introduction</h3><p>Phenotypic overlap between the two main chronic airway pulmonary diseases, asthma and chronic obstructive pulmonary disease (COPD), has been the subject of debate for decades, and recently the nomenclature of asthma-COPD overlap syndrome (ACOS) was adopted for this condition. The definition of this entity in the literature is, however, very heterogeneous, it is therefore important to define how it applies to Portugal.</p></div><div><h3>Methods</h3><p>A literature review of ACOS was made in a first phase resulting in the drawing up of a document that was later submitted for discussion among a panel of chronic lung diseases experts, resulting in reflexions about diagnosis, treatment and clinical guidance for ACOS patients.</p></div><div><h3>Results</h3><p>There was a consensus among the experts that the diagnosis of ACOS should be considered in the concomitant presence of: clinical manifestations characteristic of both asthma and COPD, persistent airway obstruction (post-bronchodilator FEV<sub>1</sub>/FVC<!--> <!--><<!--> <!-->0.7), positive response to bronchodilator test (increase in FEV<sub>1</sub> of ≥200<!--> <!-->mL and ≥12% from baseline) and current or past history of smoking or biomass exposure. In reaching diagnosis, the presence of peripheral eosinophilia (>300<!--> <!-->eosinophils/μL or >5% of leukocytes) and previous history of atopy should also be considered. The recommended first line pharmacological treatment in these patients is the ICS/LABA association; if symptomatic control is not achieved or in case of clinical severity, triple therapy with ICS/LABA/LAMA may be used. An effective control of the exposure to risk factors, vaccination, respiratory rehabilitation and treatment of comorbidities is also important.</p></div><div><h3>Conclusions</h3><p>The creation of initial guidelines on ACOS, which can be applied in the Portuguese context, has an important role in the generation of a broad nationwide consensus. This will give, in the near future, a far better clinical, functional and epidemiological characterization of ACOS patients, with the ultimate goal of achieving better therapeutic guidance.</p></div>","PeriodicalId":101122,"journal":{"name":"Revista Portuguesa de Pneumologia (English Edition)","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2017-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.rppnen.2016.11.005","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41915136","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Collective teaching of transverse flute as a component of a pulmonary rehabilitation program: An innovative study","authors":"D. Apolinário , L. Ribeiro , G. Luís , P. Almeida","doi":"10.1016/j.rppnen.2016.12.007","DOIUrl":"10.1016/j.rppnen.2016.12.007","url":null,"abstract":"","PeriodicalId":101122,"journal":{"name":"Revista Portuguesa de Pneumologia (English Edition)","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2017-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.rppnen.2016.12.007","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48254471","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
A. Feliciano , R. Linhas , R. Marçôa , A. Cysneiros , C. Martinho , R.P. Reis , D. Penque , P. Pinto , C. Bárbara
{"title":"Hematological evaluation in males with obstructive sleep apnea before and after positive airway pressure","authors":"A. Feliciano , R. Linhas , R. Marçôa , A. Cysneiros , C. Martinho , R.P. Reis , D. Penque , P. Pinto , C. Bárbara","doi":"10.1016/j.rppnen.2016.12.001","DOIUrl":"10.1016/j.rppnen.2016.12.001","url":null,"abstract":"<div><p>Obstructive sleep apnea syndrome (OSAS) is a systemic inflammatory disease associated with cardiovascular consequences. Red blood cell distribution width (RDW), mean platelet volume (MPV), and platelet distribution width (PDW) are recognized biomarkers of cardiovascular morbidity/mortality. Limited data is available on the association between these parameters and OSAS severity and the relationship with positive airway pressure therapy (PAP). In this prospective study of male OSAS patients we analyzed hematological data in order to evaluate their value in predicting OSAS severity, the relationship with sleep parameters, and their behavior under PAP. Seventy-three patients were included (mean age 46.5 years), of which 36 were mild (49.3%), 10 moderate (13.7%), and 27 severe (37%). The mean RDW increased significantly with OSAS severity and showed a positive correlation with respiratory disturbance index and hypoxemic burdens. Additionally, a group of 48 patients (mean age 47.2 years) were submitted to PAP. After six months, red blood cell count, hemoglobin, hematocrit, and platelet count showed a significant decrease (<em>p</em> <!--><<!--> <!-->0.0001; <em>p</em> <!--><<!--> <!-->0.0001; <em>p</em> <!-->=<!--> <!-->0.001; <em>p</em> <!--><<!--> <!-->0.0001; respectively). Concerning OSAS severity, these parameters also significantly decreased in mild patients (<em>p</em> <!-->=<!--> <!-->0.003; <em>p</em> <!-->=<!--> <!-->0.043; <em>p</em> <!-->=<!--> <!-->0.020; <em>p</em> <!-->=<!--> <!-->0.014; respectively) but only hemoglobin, hematocrit, and platelet count decreased in severe cases (<em>p</em> <!--><<!--> <!-->0.0001; <em>p</em> <!-->=<!--> <!-->0.008; <em>p</em> <!-->=<!--> <!-->0.018; respectively). This study demonstrated an association between RDW values and OSAS severity. Moreover, red cell and platelet parameters changed significantly after PAP, supporting its cardiovascular protective effect. RDW may become a simple/inexpensive blood biomarker, making it useful in prioritizing OSAS patients waiting for polysomnography, and red cell and platelet parameters could be useful in PAP follow up.</p></div>","PeriodicalId":101122,"journal":{"name":"Revista Portuguesa de Pneumologia (English Edition)","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2017-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.rppnen.2016.12.001","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45808174","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
V.T. Lauria , E.F. Sperandio , T.L.W. de Sousa , W. de Oliveira Vieira , M. Romiti , A.R. de Toledo Gagliardi , R.L. Arantes , V.Z. Dourado
{"title":"Evaluation of dose–response relationship between smoking load and cardiopulmonary fitness in adult smokers: A cross-sectional study","authors":"V.T. Lauria , E.F. Sperandio , T.L.W. de Sousa , W. de Oliveira Vieira , M. Romiti , A.R. de Toledo Gagliardi , R.L. Arantes , V.Z. Dourado","doi":"10.1016/j.rppnen.2016.11.007","DOIUrl":"10.1016/j.rppnen.2016.11.007","url":null,"abstract":"<div><h3>Objective</h3><p>To evaluate the dose–response relationship between smoking load and cardiopulmonary fitness, as measured with cardiopulmonary exercise testing (CPET), in adult smokers free of respiratory diseases.</p></div><div><h3>Methods</h3><p>After a complete clinical evaluation and spirometry, 95 adult smokers (35 men and 60 women) underwent CPET on a treadmill.</p></div><div><h3>Results</h3><p>The physiological responses during CPET showed lower cardiorespiratory fitness levels, regardless of smoking load, with a peak <span><math><mrow><msub><msup><mi>V</mi><mo>′</mo></msup><mrow><msub><mtext>O</mtext><mn>2</mn></msub></mrow></msub></mrow></math></span> lower than 100% of the expected value and a lower maximum heart rate. We observed a significant moderate negative correlation between smoking load and peak <span><math><mrow><msub><msup><mi>V</mi><mo>′</mo></msup><mrow><msub><mtext>O</mtext><mn>2</mn></msub></mrow></msub></mrow></math></span>. The smoking load also presented a significant negative correlation with maximum heart rate(<em>r</em> <!-->=<!--> <!-->−0.36; <em>p</em> <!--><<!--> <!-->0.05), lactate threshold(<em>r</em> <!-->=<!--> <!-->−0.45; <em>p</em> <!--><<!--> <!-->0.05), and peak ventilation(<em>r</em> <!-->=<!--> <!-->−0.43; <em>p</em> <!--><<!--> <!-->0.05). However, a dose–response relationship between smoking load quartiles and cardiopulmonary fitness was not found comparing quartiles of smoking loads after adjustment for age, sex and cardiovascular risk.</p></div><div><h3>Conclusion</h3><p>There appears to be no dose–response relationship between SL and cardiopulmonary fitness in adult smokers with preserved pulmonary function, after adjusting the analysis for age and cardiovascular risk. Our results suggest that smoking cessation might be useful as the primary strategy to prevent cardiopulmonary fitness decline in smokers, regardless of smoking load. Thus, even a very low dose of tobacco use must be avoided in preventive strategies focusing on becoming people more physically active and fit.</p></div>","PeriodicalId":101122,"journal":{"name":"Revista Portuguesa de Pneumologia (English Edition)","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2017-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.rppnen.2016.11.007","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43920526","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
D. Coutinho , A. Oliveira , S. Campainha , S. Neves , M. Guerra , J. Miranda , A. Furtado , D. Tente , A. Sanches , J. Almeida , J. Moura e Sá
{"title":"Endobronchial ultrasound-guided transbronchial needle aspiration for nodal staging in non-small cell lung carcinoma","authors":"D. Coutinho , A. Oliveira , S. Campainha , S. Neves , M. Guerra , J. Miranda , A. Furtado , D. Tente , A. Sanches , J. Almeida , J. Moura e Sá","doi":"10.1016/j.rppnen.2016.12.006","DOIUrl":"10.1016/j.rppnen.2016.12.006","url":null,"abstract":"<div><h3>Introduction</h3><p>Lung cancer staging has recently evolved to include endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) for nodal assessment.</p></div><div><h3>Aim</h3><p>Evaluate the performance and safety of EBUS-TBNA as a key component of a staging algorithm for non-small cell lung carcinoma (NSCLC) and as a single investigation technique for diagnosis and staging of NSCLC.</p></div><div><h3>Methods</h3><p>Patients undergoing EBUS-TBNA for NSCLC staging at our institution between April 1, 2010 and December 31, 2014 were consecutively included with prospective data collection. EBUS-TBNA was performed under general anesthesia through a rigid scope.</p></div><div><h3>Results</h3><p>A total of 122 patients, 84.4% males, mean age 64.2 years. Histological type: 78 (63.9%) adenocarcinoma, 33 (27.0%) squamous cell carcinoma, 11 (8.9%) undifferentiated/other NSCLC. A total of 435 lymph node stations were punctured. Median number of nodes per patient was 4. EBUS-TBNA nodal staging: 63 (51.6%) N0; 8 (6.5%) N1; 34 (27.9%) N2, and 17 (13.9%) N3. EBUS-TBNA was the primary diagnostic procedure in 27 (22.1%) patients. EBUS-TBNA NSCLC staging had a sensitivity, specificity, positive predictive value, negative predictive value, and diagnostic accuracy rate of 83.3, 100, 100, 86.1, and 91.8%, respectively. No complications were attributable to the procedure.</p></div><div><h3>Conclusion</h3><p>A comprehensive lung cancer staging strategy that includes EBUS-TBNA seems to be safe and effective. Our EBUS-TBNA performance and safety in this particular setting was in line with previously published reports. Additionally, our study showed that, in selected patients, lung cancer diagnosis and staging are achievable with a single endoscopic technique.</p></div>","PeriodicalId":101122,"journal":{"name":"Revista Portuguesa de Pneumologia (English Edition)","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2017-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.rppnen.2016.12.006","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43282543","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
R. Linhas, D. Machado, S. Campainha, S. Neves, A. Barroso
{"title":"Concomitant lung cancer and interstitial lung disease: A challenge in clinical practice","authors":"R. Linhas, D. Machado, S. Campainha, S. Neves, A. Barroso","doi":"10.1016/j.rppnen.2016.11.008","DOIUrl":"10.1016/j.rppnen.2016.11.008","url":null,"abstract":"","PeriodicalId":101122,"journal":{"name":"Revista Portuguesa de Pneumologia (English Edition)","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2017-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.rppnen.2016.11.008","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41817390","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Gln223Arg polymorphism in the Caucasian population and Pro1019Pro polymorphism in the Chinese population are risk factors for OSAS: An updated meta-analysis of 1159 subjects","authors":"B. Xu , J. Liu , T. Li , S. Liu","doi":"10.1016/j.rppnen.2016.12.002","DOIUrl":"10.1016/j.rppnen.2016.12.002","url":null,"abstract":"<div><h3>Background</h3><p>We conducted a meta-analysis of published literature to identify the correlation between leptin receptor gene polymorphisms and the risk of obstructive sleep apnea syndrome (OSAS).</p></div><div><h3>Methods</h3><p>Five different single nucleotide polymorphisms (SNPs) were studied. Only Gln223Arg and Pro1019Pro had multiple studies. Nine studies focused on the correlation between Gln223Arg and Pro1019Pro polymorphisms and OSAS risk. Fixed-effects model or random-effects model was used to calculate the pooled odds ratio (ORs) and its corresponding 95% confidence interval (95% CI). The Begg's, Egger's, Perter's and Harbord tests were used to measure publication bias. Sensitivity analysis was also performed to ensure the robustness of the findings.</p></div><div><h3>Results</h3><p>Six studies on Gln223Arg polymorphisms (661 cases and 498 controls) and three studies on Pro1019Pro polymorphisms (561 cases and 561 controls) were extracted. There was no correlation between the leptin receptor Gln223Arg polymorphism and the risk of OSAS (odd ratio<!--> <!-->=<!--> <!-->0.86, 95% CI<!--> <!-->=<!--> <!-->0.68–1.10, <em>P</em> <!-->=<!--> <!-->0.23). However, Caucasian OSAS patients had a higher Arg allele frequency; whereas Chinese population with G genotype were more susceptible to OSAS (odd ratio<!--> <!-->=<!--> <!-->1.28, 95% CI<!--> <!-->=<!--> <!-->1.04–1.57, <em>P</em> <!-->=<!--> <!-->0.02) in the studies on Pro1019Pro polymorphisms.</p></div><div><h3>Conclusion</h3><p>The Gln223Arg polymorphisms in the Caucasian population and the Pro1019Pro polymorphisms in the Chinese population are risk factors for OSAS.</p></div>","PeriodicalId":101122,"journal":{"name":"Revista Portuguesa de Pneumologia (English Edition)","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2017-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.rppnen.2016.12.002","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49260297","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}